LIGAND PHARMACEUTICALS INCORPORATED
Net Cash Flow Breakdown
Total Cash from Operations: $20.7M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $377.0K | 1.8% |
| Business Acquisitions | $3.6M | 17.3% |
| Other Investing | $853.8K | 4.1% |
| Other Financing | $15.9M | 76.8% |
| Net Cash Flow | $0 | 0.0% |